Q4 2025 Earnings Call March 3, 2026 4:00 AM ESTCompany ParticipantsGavin Griggs - CEO & Executive DirectorMatthew Webb - ...
Changes to a key component of the Patient Driven Payment Model remain in limbo two years after they were first proposed, but federal regulators are still poised to refine the system to accommodate for ...
BACKGROUND: Right ventricular failure drives both morbidity and mortality in pulmonary arterial hypertension (PAH), but the mechanism of transition from compensated right ventricle (cRV) to ...
SGT-003 in the INSPIRE DUCHENNE trial to date - - Robust microdystrophin expression with consistent mechanistic evidence of dystrophin associated protein complex ...
Solid Biosciences Inc. shares dropped more than 8% on Wednesday after the company released data from its Duchenne gene therapy trial. Trading in the stock was briefly halted earlier in the day. The ...
Myocardial ischemia, the primary driver of heart attacks, remains the leading cause of death and disability worldwide. Delays in diagnosis directly correlate with increased myocardial necrosis, higher ...